1-2 of 2
Maaike E Heidinga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Midostaurin in Patients (Pts) with Newly Diagnosed FLT3 -Mutation Negative Acute Myeloid Leukemia (AML): Final Results and Measurable Residual Disease (MRD) Analyses from the Unify Trial

Jacqueline J Cloos, Pau Montesinos, Walter Fiedler, Rouven Müller, Jürgen Krauter, Simona Sica, Jörg Westermann, Maaike E Heidinga, Lok Lam Ngai, Yvonne J.M Oussoren-Brockhoff, Hartmut Döhner, Mark Levis, Gert J. Ossenkoppele, Richard M. Stone, Giedre Koenen, Bourras-Rezki Bengoudifa, Yuan Cheng, Thierry Medts, Valerie Heidinger, Carolin Sachs, Jorge Sierra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1303.
https://doi.org/10.1182/blood-2021-148129
Published: 2021
Journal Articles

Best Practices for Validation of Measurable Residual Disease Assessments By Multiparameter Flow Cytometry in Emerging Clinical Trials of Acute Myeloid Leukemia

Pavinder Kaur, Anil Pahuja, Kevin Nguyen, Pedro Marques Ramos, PhD, Ling Du, PhD, Jacqueline J Cloos, Maaike E Heidinga, Yvonne J.M Oussoren-Brockhoff, Angele Kelder, Xun Li, Sarah Larson, MD, Shabnam Tangri, Ghanashyam Sarikonda, Naveen Dakappagari
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-137787
Published: 2020